CA2794123A1 - Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues - Google Patents

Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues Download PDF

Info

Publication number
CA2794123A1
CA2794123A1 CA2794123A CA2794123A CA2794123A1 CA 2794123 A1 CA2794123 A1 CA 2794123A1 CA 2794123 A CA2794123 A CA 2794123A CA 2794123 A CA2794123 A CA 2794123A CA 2794123 A1 CA2794123 A1 CA 2794123A1
Authority
CA
Canada
Prior art keywords
cells
bdca
antigen
cell
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2794123A
Other languages
English (en)
Inventor
Juergen Schmitz
Andrzej Dzionek
David William Buck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miltenyi Biotec GmbH
Original Assignee
Miltenyi Biotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miltenyi Biotec GmbH filed Critical Miltenyi Biotec GmbH
Priority claimed from CA2396428A external-priority patent/CA2396428C/fr
Publication of CA2794123A1 publication Critical patent/CA2794123A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2794123A 1999-11-15 2000-11-15 Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues Abandoned CA2794123A1 (fr)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US16555599P 1999-11-15 1999-11-15
US60/165,555 1999-11-15
US16707699P 1999-11-23 1999-11-23
US60/167,076 1999-11-23
US17900300P 2000-01-28 2000-01-28
US60/179,003 2000-01-28
US18077500P 2000-02-07 2000-02-07
US60/180,775 2000-02-07
US19682400P 2000-04-11 2000-04-11
US60/196,824 2000-04-11
US19720500P 2000-04-13 2000-04-13
US60/197,205 2000-04-13
CA2396428A CA2396428C (fr) 1999-11-15 2000-11-15 Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2396428A Division CA2396428C (fr) 1999-11-15 2000-11-15 Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues

Publications (1)

Publication Number Publication Date
CA2794123A1 true CA2794123A1 (fr) 2001-05-25

Family

ID=47215974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2794123A Abandoned CA2794123A1 (fr) 1999-11-15 2000-11-15 Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues

Country Status (1)

Country Link
CA (1) CA2794123A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014058915A3 (fr) * 2012-10-08 2014-05-30 St. Jude Children's Research Hospital Thérapies fondées sur la stabilité et la fonction des lymphocytes t régulateurs par l'intermédiaire d'un axe neuropiline-1:sémaphorine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014058915A3 (fr) * 2012-10-08 2014-05-30 St. Jude Children's Research Hospital Thérapies fondées sur la stabilité et la fonction des lymphocytes t régulateurs par l'intermédiaire d'un axe neuropiline-1:sémaphorine
US9540439B2 (en) 2012-10-08 2017-01-10 St. Jude Children's Research Hospital Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis
AU2013329372B2 (en) * 2012-10-08 2018-07-12 St. Jude Children's Research Hospital Therapies based on control of regulatory T cell stability and function via a Neuropilin-1:Semaphorin axis

Similar Documents

Publication Publication Date Title
US20200283499A1 (en) Use of an antibody specific for BDCA 2 for ligation and removal of dendritic cells in the treatment systemic lupus erythematosis
CA2664137C (fr) Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues
Sumitran-Holgersson et al. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts1
JP5560301B2 (ja) ４ｉｇ−ｂ７−ｈ３およびその対応するｎｋ細胞受容体を標的化する治療および診断方法ならびに組成物
US5514364A (en) Non-lethal methods for conditioning a recipient for bone marrow transplantation
JPH10513347A (ja) 組換え型ヒトα−フェトプロテインおよびその利用
US20030022249A1 (en) Antigen-binding fragments that recognize a subset of dendritic cells and methods of use thereof
US5786160A (en) Natural killer cell-specific antigen and antibodies that identify the same
Scriba et al. Phenotype of rat monocytes during acute kidney allograft rejection: increased expression of NKR‐P1 and reduction of CD43
Zapata et al. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
CA2794123A1 (fr) Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues
Yoshida et al. Leukocyte integrin‐dependent and antibody‐independent cytotoxicity of macrophage against allografts
Graham et al. Surface carbohydrate epitopes of Thy‐1.1 and Thy‐1.2 thymocytes are distinguished by a monoclonal antibody with a specificity common to peanut agglutinin

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150212